This paper has the interest of finding the approximate solution (APPS) of a nonlinear variable coefficients hyperbolic boundary value problem (NOLVCHBVP). The given boundary value problem is written in its discrete weak form (WEFM) and proved have a unique solution, which is obtained via the mixed Galerkin finite element with implicit method that reduces the problem to solve the Galerkin nonlinear algebraic system (GNAS). In this part, the predictor and the corrector techniques (PT and CT, respectively) are proved at first convergence and then are used to transform the obtained GNAS to a linear GLAS . Then the GLAS is solved using the Cholesky method (ChMe). The stability and the convergence of the method are studied. Some illustrative examples are used, where the results are given by figures that show the efficiency and accuracy for the method.
This paper is concerned with finding the approximation solution (APPS) of a certain type of nonlinear hyperbolic boundary value problem (NOLHYBVP). The given BVP is written in its discrete (DI) weak form (WEF), and is proved that it has a unique APPS, which is obtained via the mixed Galerkin finite element method (GFE) with implicit method (MGFEIM) that reduces the problem to solve the Galerkin nonlinear algebraic system (GNAS). In this part, the predictor and the corrector technique (PT and CT) are proved convergent and are used to transform the obtained GNAS to linear (GLAS ), then the GLAS is solved using the Cholesky method (ChMe). The stability and the convergence of the method are studied. The results are given by figures and shown the efficiency and accuracy for the method
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.